A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : HAART

Search Conditions:
Search Keyword : HAART
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: HAART
Appearance Frequency: 8794 time(s)
Long forms: 43

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
highly active antiretroviral therapy
(8719 times)
Acquired Immunodeficiency Syndrome
(2087 times)
HIV (1852 times)
CI (505 times)
AIDS (436 times)
1997 Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
highly active ART
(24 times)
Medicine
(5 times)
ART (22 times)
HIV (8 times)
TB (3 times)
2001 Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.
highly active ARV therapy
(5 times)
Medicine
(2 times)
ARV (2 times)
ARVs (2 times)
HIV (2 times)
2005 Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
HIV patients receiving antiretroviral therapy
(4 times)
Dentistry
(2 times)
CAL (1 time)
CI (1 time)
HP (1 time)
2006 Symptom exacerbation and adherence to antiretroviral therapy during the menstrual cycle: a pilot study.
cocktails-high active anti-retroviral therapy
(2 times)
Drug Therapy
(2 times)
AIDS (2 times)
HIV (1 time)
2015 New Perspectives of HIV/AIDS Therapy Study.
HIV infection and long-term antiretroviral therapy
(2 times)
Communicable Diseases
(1 time)
MFI (1 time)
2004 [CD38 antigen as a marker for immunological follow-up in HIV-positive patients].
HIV/AIDS on anti-retroviral therapy
(2 times)
Dermatology
(1 time)
ACLD (1 time)
TMP-SMX (1 time)
2011 Photolichenoid plaques with associated vitiliginous pigmentary changes.
anti-HIV therapy
(1 time)
Internal Medicine
(1 time)
--- 2009 [Practice of anti-HIV therapy (HAART)].
anything about antiretroviral treatment
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
ARVs (1 time)
MTCT (1 time)
TB (1 time)
2005 Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
10  H. pylori, fungal colonization, and antiretroviral treatment
(1 time)
Medicine
(1 time)
GI (1 time)
2006 Morphological changes of the upper gastrointestinal tract mucosa and Helicobacter pylori infection in HIV-positive patients with severe immunodeficiency and symptoms of dyspepsia.
11  HAART cohort
(1 time)
Medicine
(1 time)
CI (1 time)
DM (1 time)
HCV (1 time)
2018 Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study.
12  HAART group
(1 time)
Anti-Bacterial Agents
(1 time)
SILs (1 time)
2007 Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
13  HAART responders
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
FGF-2 (1 time)
TNF-alpha (1 time)
2011 The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
14  HAART use group
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HR (2 times)
CI (1 time)
HZ (1 time)
2014 Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.
15  has been reported that antiretroviral therapy
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
IFN-gamma (1 time)
IL-2 (1 time)
2005 Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.
16  has changed after the introduction of new potent antiretroviral therapies
(1 time)
Medicine
(1 time)
--- 2000 [The efficacy of antiretroviral treatment in patients with human immunodeficiency virus infection. A study of 807 patients].
17  has declined considerably with the introduction of tritherapy
(1 time)
Pulmonary Medicine
(1 time)
--- 2007 [Lung cancer in HIV-positive patients].
18  has not shown a benefit in patients on tri-therapy
(1 time)
Communicable Diseases
(1 time)
ART (2 times)
HIV (1 time)
2005 [Human immunodeficiency virus (HIV) infection in pregnancy: antiretroviral treatment (ART) and mode of delivery].
19  has profound negative effect on the optic nerve even though
(1 time)
Medicine
(1 time)
HIV (1 time)
ONSD (1 time)
SD (1 time)
2019 Transorbital sonographic measurement of optic nerve sheath diameter among HIV-Positive patients in Northwestern Nigeria.
20  have been achieved since the introduction of the combination therapy
(1 time)
Chemistry
(1 time)
--- 2015 Improving bioavailability and biodistribution of anti-HIV chemotherapy.
21  have been associated with the medication regimen
(1 time)
General Surgery
(1 time)
--- 2006 HIV and hyperlipidemia: current recommendations and treatment.
22  have explored socioeconomic status, access to triple therapy
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
RR (1 time)
2002 Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
23  hemerocallidea extract and antiretroviral therapy
(1 time)
Reproductive Medicine
(1 time)
HH (1 time)
2016 Effect of co-administration of Hypoxis hemerocallidea extract and antiretroviral therapy (HAART) on the histomorphology and seminal parameters in Sprague Dawley rats.
24  hemispherical aortic annuloplasty reconstructive technology
(1 time)
Cardiology
(1 time)
--- 2022 Four-dimensional magnetic resonance after ascending aorta replacement and aortic valve repair with HAART 300 internal annuloplasty ring.
25  hepatitis B and C seropositivity in treatment with antiretroviral drugs
(1 time)
Endocrine System Diseases
(1 time)
--- 2019 Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.
26  high acting anti-retrovirals
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 2002 Adherence discourse among African-American women taking HAART.
27  highly promising agents for use as an effective anti-retroviral therapy
(1 time)
Computational Biology
(1 time)
RT (1 time)
2021 Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents.
28  HIV in patients on optimal long-term antiretroviral therapy
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 2012 Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.
29  HIV infected females on antiretroviral therapy
(1 time)
Medicine
(1 time)
PROG (1 time)
2017 Impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in premenopausal HIV infected females at NAUTH, Nnewi, Nigeria.
30  HIV infected patients after treatment with combinations of drugs
(1 time)
Chemistry
(1 time)
--- 2003 Reservoirs of HIV replication after successful combined antiretroviral treatment.
31  HIV infection and cytomegalovirus retinitis in whom antiretroviral therapy
(1 time)
Communicable Diseases
(1 time)
--- 2001 Simultaneous occurrence of 2 HIV-related immunereconstitution diseases after initiation of highly active antiretroviral therapy.
32  HIV infection in spite of successful anti-retroviral therapy
(1 time)
Cell Biology
(1 time)
--- 2014 Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity.
33  HIV positive patients undergoing treatment with antiretroviral drugs
(1 time)
General Surgery
(1 time)
PLA (1 time)
2004 Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART).
34  HIV receive antiretroviral therapy
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
PLHIV (1 time)
2016 Model of socio-cultural dimensions involved in adherence to antiretroviral therapy for HIV/AIDS in public health care centers in Chile.
35  HIV-1 infection, who was asymptomatic without antiretroviral therapy
(1 time)
Medicine
(1 time)
PI (1 time)
2005 Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
36  HIV-1 transmission by antiviral
(1 time)
Molecular Biology
(1 time)
CTLs (1 time)
DCs (1 time)
ODNs (1 time)
2005 CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
37  HIV-combination therapy
(1 time)
Substance-Related Disorders
(1 time)
--- 2003 Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence.
38  HIV-infected children taking protease inhibitors combined with transcriptase inhibitors
(1 time)
Medicine
(1 time)
--- 2004 [Cytomegalovirus retinitis in pediatric patients with AIDS receiving highly active antiretrovirus therapy].
39  HIV-infected men receiving effective antiretroviral therapy
(1 time)
Medicine
(1 time)
--- 2012 Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.
40  HIV-infected subjects and decreases after antiretroviral therapy
(1 time)
Allergy and Immunology
(1 time)
sHLA-A,-B,-C (1 time)
sHLA-G (1 time)
2009 Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
41  HIV-positive patients receiving antiretroviral treatment
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HCV (1 time)
IFN-gamma (1 time)
qRT-PCR (1 time)
2007 Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
42  HIV/AIDS and its association with adherence to antiretroviral therapy
(1 time)
Public Health
(1 time)
aPR (1 time)
CI (1 time)
IQR (1 time)
2016 [Stigma related to HIV/AIDS associated with adherence to antiretroviral therapy in patients of a public hospital in Lima, Peru 2014].
43  HIV/AIDS chemotherapy
(1 time)
Communicable Diseases
(1 time)
AIDS (1 time)
HIV (1 time)
2017 HAART in HIV/AIDS Treatments: Future Trends.